Latest Articles
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced - PharmiWeb.com
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced PharmiWeb.com
Published: Aug. 26, 2025, 4:10 p.m.
Rina-S Wins FDA Breakthrough Therapy Designation for Advanced or Recurrent Endometrial Cancer - OncLive
Rina-S Wins FDA Breakthrough Therapy Designation for Advanced or Recurrent Endometrial Cancer OncLive
Published: Aug. 26, 2025, 3:01 p.m.
Genmab Receives FDA Breakthrough Therapy Designation for - GlobeNewswire
Genmab Receives FDA Breakthrough Therapy Designation for GlobeNewswire
Published: Aug. 26, 2025, 12:06 p.m.
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced Endometrial Cancer (EC) - Yahoo Finance
Genmab Receives FDA Breakthrough Therapy Designation for Rinatabart Sesutecan (Rina-S®) in Advanced Endometrial Cancer (EC) Yahoo Finance
Published: Aug. 26, 2025, noon
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial - Nature
Maintenance olaparib after platinum-based chemotherapy for advanced/metastatic endometrial cancer: GINECO randomized phase IIb UTOLA trial Nature
Published: Aug. 26, 2025, 11:43 a.m.
GSK expands cancer treatment options in India with launch of immunotherapy and PARP inhibitor - connectedtoindia.com
GSK expands cancer treatment options in India with launch of immunotherapy and PARP inhibitor connectedtoindia.com
Published: Aug. 26, 2025, 4:39 a.m.
Immunotherapy for High-Grade Endometrial Stromal Sarcoma: A Narrative Review Bridging Molecular Insights to Clinical Translation - Frontiers
Immunotherapy for High-Grade Endometrial Stromal Sarcoma: A Narrative Review Bridging Molecular Insights to Clinical Translation Frontiers
Published: Aug. 25, 2025, 10:47 a.m.
World-first therapy to target endometriosis and deadly cancer - Herald Sun
World-first therapy to target endometriosis and deadly cancer Herald Sun
Published: Aug. 24, 2025, noon
World-first therapy to target endometriosis and deadly cancer - The Mercury
World-first therapy to target endometriosis and deadly cancer The Mercury
Published: Aug. 23, 2025, 7:06 p.m.
World-first therapy to target endometriosis and deadly cancer - Gold Coast Bulletin
World-first therapy to target endometriosis and deadly cancer Gold Coast Bulletin
Published: Aug. 23, 2025, 7:02 p.m.
Link copied to clipboard!